Skip to main content

Danielle M. Brander, MD

Danielle Brander, MD
Videos
11/26/2024
Danielle Brander, MD, highlights current trends in the community oncology setting for treating chronic lymphocytic leukemia (CLL) and how clinical pathways can assist oncologists with decision making for frontline therapy in CLL.
Danielle Brander, MD, highlights current trends in the community oncology setting for treating chronic lymphocytic leukemia (CLL) and how clinical pathways can assist oncologists with decision making for frontline therapy in CLL.
Danielle Brander, MD, highlights...
11/26/2024
Journal of Clinical Pathways
Danielle Brander, MD
Videos
11/22/2024
Danielle Brander, MD, discusses the latest National Comprehensive Cancer Network guidelines for chronic lymphocytic leukemia (CLL) and the efficacy of BTK inhibitors as monotherapy in the frontline treatment of CLL.
Danielle Brander, MD, discusses the latest National Comprehensive Cancer Network guidelines for chronic lymphocytic leukemia (CLL) and the efficacy of BTK inhibitors as monotherapy in the frontline treatment of CLL.
Danielle Brander, MD, discusses...
11/22/2024
Journal of Clinical Pathways